Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

<p>Abstract</p> <p>Purpose</p> <p>To evaluate efficacy and toxicity clinical in the intensified treatment of locally advanced squamous cell carcinoma of the head and neck (SCCHN) with the combination of chemotherapy, the EGFR antibody cetuximab, and intensity-modulated...

Full description

Bibliographic Details
Main Authors: Jensen Alexandra D, Krauss Jürgen, Potthoff Karin, Simon Christian, Nikoghosyan Anna V, Lossner Karen, Debus Jürgen, Münter Marc W
Format: Article
Language:English
Published: BMC 2012-04-01
Series:Radiation Oncology
Subjects:
Radiochemotherapy
Radioimmunotherapy
Cetuximab
IMRT
Concomitant boost
Squamous cell head and neck cancer
SCCHN
Online Access:http://www.ro-journal.com/content/7/1/57

Internet

http://www.ro-journal.com/content/7/1/57

Similar Items